wegovy is semaglutide More than 170,000 people in U.S. are taking pill, Novo Nordisk says Wegovy® Pen | Hims

Patients should avoid empty calories from sugar-sweetened beverages and ultra-processed foods, which provide minimal nutritional value

Conclusions Current evidence indicates that KD has several benefits beyond weight loss, including improved mental health

The approval was based on OASIS 4 trial (307 patients): 16.6% mean weight loss with once-daily oral semaglutide 25 mg Weight loss comparable to injectable Wegovy 2.4 mg One in three patients achieved 20% weight loss Novo Nordisk plans a US launch in early January 2026, with EMA review already in progress

some work in inflammatory bowel disease (PMID: 22300085) A clinical trial has been registered, though its current status is unclear (PMID: 40756949) Regulatory note: BPC-157 is prohibited by WADA/USADA for sport use (added to the Prohibited List in 2022)